Test Bank for Ruppel’s Manual of Pulmonary Function Testing
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
, ANS: B
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter
1). Antigens csuch cas canimal cdander, cpollens, cand cdusts care cthe cmost ccommon ctriggers.
cOther ccommon ctriggers cinclude cexposure cto cair cpollutants cand cexercise cin ccold cor
cdry cair.
DIF: 2 REF: p. c16 OBJ: EL-3 MSC: cNBRC: cNone
8. Which cof cthe cfollowing cstatements cconcerning ctumors cin cthe cupper cairway cis ctrue?
a. There cmay cbe cvariable cor cfixed cobstruction.
b. Fixed cobstruction cwill cbe cpresent.
c. Variable cobstruction cwill cbe cpresent.
d. Small cairway cobstruction cwill cresult.
ANS: cA
Tumors cinvolving cthe cupper cairway cmay ccause cvariable cor cfixed cobstruction.
DIF: 2 REF: p. c19 OBJ: EL-2
cMSC: cNBRC: cCPFT c3C-3
9. Sarcoidosis cis ca csystemic cdisorder cthat cusually ccauses cwhich cof cthe cfollowing?
a. A crestrictive cventilatory cdefect
b. An cobstructive cventilatory cdefect
c. Hyperreactive cairways
d. Primary cpulmonary chypertension
ANS: cA
Restriction cis coften cassociated cwith cthe cfollowing: cinterstitial clung cdiseases, cincluding
cidiopathic cfibrosis, cpneumoconioses, cand csarcoidosis.
DIF: 1 REF: p. c19 c| cp. c21 OBJ: EL-3 MSC: cNBRC: cNone
10. For cwhich cof cthe cfollowing cconditions cmight cpulmonary cfunction ctesting cbe
ccontraindicated?
a. Vocal ccord cdysfunction
b. Untreated cpneumothorax
c. Congestive cheart cfailure c(CHF)
d. Bronchiolitis cobliterans
ANS: cB
Pulmonary cfunction ctests care cusually ccontraindicated cin cthe cpresence cof cpneumothorax.
cHowever, cundiagnosed cpneumothorax cmay cpresent ca crisk cif cpulmonary cfunction cstudies
care cperformed.
DIF: 1 REF: p. c23 OBJ: EL-4
cMSC: cNBRC: cCPFT c2B-6
d.
11. Which cof cthe cfollowing ccorrectly cdescribe(s) cappropriate cphysical cmeasurements
cbefore cpulmonary cfunction ctesting?
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
, ANS: B
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter
1). Antigens csuch cas canimal cdander, cpollens, cand cdusts care cthe cmost ccommon ctriggers.
cOther ccommon ctriggers cinclude cexposure cto cair cpollutants cand cexercise cin ccold cor
cdry cair.
DIF: 2 REF: p. c16 OBJ: EL-3 MSC: cNBRC: cNone
8. Which cof cthe cfollowing cstatements cconcerning ctumors cin cthe cupper cairway cis ctrue?
a. There cmay cbe cvariable cor cfixed cobstruction.
b. Fixed cobstruction cwill cbe cpresent.
c. Variable cobstruction cwill cbe cpresent.
d. Small cairway cobstruction cwill cresult.
ANS: cA
Tumors cinvolving cthe cupper cairway cmay ccause cvariable cor cfixed cobstruction.
DIF: 2 REF: p. c19 OBJ: EL-2
cMSC: cNBRC: cCPFT c3C-3
9. Sarcoidosis cis ca csystemic cdisorder cthat cusually ccauses cwhich cof cthe cfollowing?
a. A crestrictive cventilatory cdefect
b. An cobstructive cventilatory cdefect
c. Hyperreactive cairways
d. Primary cpulmonary chypertension
ANS: cA
Restriction cis coften cassociated cwith cthe cfollowing: cinterstitial clung cdiseases, cincluding
cidiopathic cfibrosis, cpneumoconioses, cand csarcoidosis.
DIF: 1 REF: p. c19 c| cp. c21 OBJ: EL-3 MSC: cNBRC: cNone
10. For cwhich cof cthe cfollowing cconditions cmight cpulmonary cfunction ctesting cbe
ccontraindicated?
a. Vocal ccord cdysfunction
b. Untreated cpneumothorax
c. Congestive cheart cfailure c(CHF)
d. Bronchiolitis cobliterans
ANS: cB
Pulmonary cfunction ctests care cusually ccontraindicated cin cthe cpresence cof cpneumothorax.
cHowever, cundiagnosed cpneumothorax cmay cpresent ca crisk cif cpulmonary cfunction cstudies
care cperformed.
DIF: 1 REF: p. c23 OBJ: EL-4
cMSC: cNBRC: cCPFT c2B-6
d.
11. Which cof cthe cfollowing ccorrectly cdescribe(s) cappropriate cphysical cmeasurements
cbefore cpulmonary cfunction ctesting?
